S-500-119
Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Sponsored by Mitch McConnell (R-KY)
What it does
This bill would reauthorize two programs from the 2018 SUPPORT for Patients and Communities Act through fiscal year 2030: (1) a workforce grant program that funds job training, vocational education, and employment services for people in recovery from substance use disorders, and (2) a recovery housing pilot program that provides transitional housing for people in recovery. It would increase annual funding for the workforce grant program from $5 million to $12 million per year, update the data baselines used to determine which states and communities receive priority for grants (shifting from 2013–2017 data to 2018–2022 data), and allow up to 5% of workforce grant funds to be used for transportation to work, job training, or treatment sites.
Who benefits
People in recovery from substance use disorders who need employment support or transitional housing. Nonprofit organizations and community groups that administer these grants. Employers who gain workers who have completed recovery-linked job training. States and localities with high overdose death rates, high unemployment, and low labor force participation — which receive priority under the updated grant formula. Transportation providers contracted to serve grant recipients. Families of people in recovery who may benefit from improved employment and housing stability outcomes.
Who is hurt
States and localities that ranked highly under the older 2013–2017 data baseline but may rank lower under the updated 2018–2022 data, potentially losing grant priority. Organizations that currently receive grants and may face competition from newly prioritized applicants. Taxpayers who bear the cost of the increased annual authorization ($12M vs. $5M per year). Uninsured or underserved individuals whose needs fall outside the specific employment and housing focus of these programs may see no direct benefit despite having substance use disorders.
Supporters argue
Supporters argue that the original CAREER Act programs have expired and that reauthorization is urgently needed given that drug overdose deaths reached a record 107,500 in 2023, according to CDC data. They contend that stable employment and housing are evidence-based pillars of sustained recovery, and that increasing the annual authorization from $5 million to $12 million reflects the scale of the ongoing crisis. The bipartisan sponsorship — including Senators McConnell, Hagerty, and Fetterman — reflects broad agreement that workforce reintegration reduces relapse rates and long-term public costs.
Opponents argue
Opponents argue that $12 million per year remains a modest sum relative to the scale of the overdose crisis and that reauthorizing narrow workforce and housing pilots without broader treatment funding may create an illusion of action while leaving core gaps unaddressed. They contend that the bill's restriction barring the Secretary from directing grant funds toward non-enumerated activities could reduce program flexibility and limit grantees' ability to respond to local needs that fall outside the bill's specific categories, potentially reducing effectiveness in communities with complex, overlapping challenges.